| Date Filed | Type | Description |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/08/2012 |
SC 13G/A
| ERESEARCHTECHNOLOGY INC reports a |
| 07/13/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 07/13/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/13/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/09/2012 |
8-K
| Quarterly results |
| 07/09/2012 |
8-K
| Entered into consulting agreement|
Docs:
|
"Agreement and Plan of Merger, by and among invivodata, Inc., Explorer Holdings, Inc., eResearchTechnology, Inc. (as successor to Explorer Acquisition Corp.), Impact Acquisition Corp. and Fortis Advisors LLC",
"Amended and Restated Certificate of Incorporation of eResearchTechnology, Inc",
"Amended and Restated Bylaws of eResearchTechnology, Inc",
"Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT , a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations , announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million. Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, “As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued develo...",
"ERT Acquires invivodata to Establish the Industry's Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations , announced today the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes solutions and PRO Consulting services, based in Pittsburgh, PA. The transaction was facilitated by the San Francisco-based private equity group, Genstar Capital, LLC who last week announced that they had completed the acquisition of ERT. The acquisition immediately positions ERT as a leader in Clinical Outcome Assessments . The combined organization will now offer sponsors, CROs and ot..." |
|
| 07/03/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/12/2012 |
8-K
| Class action lawsuit filed |
| 05/21/2012 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/07/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 05/07/2012 |
8-K
| Quarterly results |
| 05/04/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 04/30/2012 |
10-K/A
| Annual Report for the period ended December 31, 2011 [amend] |
| 04/11/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/10/2012 |
8-K
| Form 8-K - Current report |
| 04/10/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/02/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 03/01/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2012 |
8-K
| Quarterly results |
| 02/14/2012 |
SC 13G/A
| ERESEARCHTECHNOLOGY INC reports a 11.4% stake in ERESEARCHTECHNOLOGY INC |
| 02/10/2012 |
SC 13G/A
| ERESEARCHTECHNOLOGY INC reports a 10% stake in ERESEARCH TECHNOLOGY INC |
| 02/10/2012 |
SC 13G/A
| ERESEARCHTECHNOLOGY INC reports a 8% stake in ERESEARCH TECHNOLOGY INC |
| 02/09/2012 |
SC 13G
| ERESEARCHTECHNOLOGY INC reports a 5.1% stake in eResearchTechnology Inc |
| 02/06/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 01/30/2012 |
SC 13G
| TOCQUEVILLE ASSET MANAGEMENT LP reports a 8.1% stake in eResearch Technology, Inc. |
| 11/07/2011 |
10-Q
| Quarterly Report for the period ended September 30, 2011 |
|